Dalia Rotstein

Dr. Dalia Rotstein is an associate professor of medicine at the University of Toronto, and neurologist specialized in multiple sclerosis (MS) and other demyelinating diseases at the Barlo MS Clinic at St. Michael’s Hospital. She completed neurology residency at University of Toronto where she was co-chief resident and MS fellowship at the Brigham and Women’s Hospital/Harvard University, where she also earned a Master of Public Health degree.

 Her mission is to enhance knowledge of MS and other demyelinating diseases in diverse populations including women, immigrants, and underrepresented ethnic groups, with the goal of promoting more inclusive care and equitable outcomes. Her research has focused on the effects of Epstein Barr virus (EBV) infection, sex, and migration on MS risk and disease course. She is currently investigating the association between EBV and risk of disease across multiple immune-mediated diseases (lupus, rheumatoid arthritis, and inflammatory bowel disease) in addition to MS.

 Her other long-term goal is improving diagnosis and treatment of rare demyelinating diseases, particularly neuromyelitis optica spectrum disease (NMOSD) and MOG antibody disease (MOGAD), in Canada. She is the Principal Investigator for CANOPTICS, a national Canadian observational study investigating adults with NMOSD, MOG Antibody Disease, and other atypical demyelinating conditions. She is the vice president of the Canadian Network of MS Clinics and serves on the Editorial Board of the journal Neurology.

Other Appointments & Affiliations

• Neurologist, Multiple Sclerosis Clinic, St. Michael’s Hospital
• Associate Professor, Department of Medicine, Division of Neurology, University of Toronto.